OCALIVA® (obeticholic acid) product information is for informational purposes only and not intended as promotion
Guidelines and Presentations
Select a resource below to view more information on clinical practice guidelines, our congress presentations, research and grant opportunities.
PBC: 2018 AASLD PRACTICE GUIDANCEVIEW GUIDANCE >
PBC: 2021 AASLD PRACTICE GUIDANCE UPDATEVIEW GUIDANCE >
INTERCEPT CONGRESS PRESENTATIONSDOWNLOAD PDF >
Educational Practice Tools
The PBC Patient Care Pathway is a tool that allows healthcare professionals to navigate the considerations around diagnosis, treatment, and routine monitoring of patients with PBC and allows the user to select the options that best align with their clinical practice.
Request an MSL Visit
Medical Science Liaisons (MSLs) are your conduit to clinical research, important product information, and disease state education. If you would like a virtual or in-person visit with an Intercept MSL, send an email request to email@example.com. Please include your full name, city, and state where you practice (so that we can inform the MSL in your area), the best way to reach you (email and phone number), and the topic of discussion.
Investigator Initiated Research
We support independent, unsolicited research related to progressive non-viral liver diseases. For questions, or to submit a proposal for consideration, email IIR@interceptpharma.com.
Medical Educational Grants
Educational grants may be awarded to academic centers, hospitals, medical societies, professional associations or governmental agencies that sponsor and develop educational programs designed to meet the needs of healthcare professionals, researchers/scientists and patients.
We are a company rooted in the pursuit of effective treatments for patients with non-viral liver diseases. Learn more about our current clinical trials.